SCHEMBL19799320

SCHEMBL19799320

Cc1c(C)c2c(c3ccccc3n2Cc2ccccc2)c2c1c1ccccc1n2C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPK1 P28482 1/20 0.46
KDM4E B2RXH2 5/20 0.45
MAPT P10636 3/20 0.45
P2RX4 Q99571 2/20 0.45
ALDH1A1 P00352 4/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19799321 0.92 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19799319 0.92 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19799316 0.92 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19799315 0.90 CYP19A1 (0.51) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19769699 0.86 CYP19A1 (0.50) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19797642 0.82 KDM4E (0.59) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL19769696 0.81 CYP19A1 (0.54) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19769698 0.81 CYP19A1 (0.54) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19769916 0.81 CYP19A1 (0.54) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL30234033 0.80 CYP19A1 (0.70) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180026204-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OXER1, OR10J3, OR51E2 CYP19A1 725/4885SMN1; SMN2 4579/4885MEN1 2925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.